SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Total debt minus cash and cash equivalents
Latest
$-4.55M
↑ 67% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
$-13.78M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-4.55M | -7.6% |
| 2024 | $-4.23M | +91.7% |
| 2023 | $-50.66M | -455.6% |
| 2022 | $-9.12M | +63.1% |
| 2021 | $-24.69M | -450.6% |
| 2020 | $-4.48M | -447.2% |
| 2019 | $1.29M | - |